NFKB1 and cancer: Su and colleagues found that CD10 + GPR77 + CAFs promote tumor formation and chemoresistance by providing a niche for cancer stem cells through activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) [45].